APA (7th ed.) Citation

Fu, K., Xie, F., Wang, F., & Fu, L. (2022). Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. Journal of hematology and oncology, 15(1), 173-32. https://doi.org/10.1186/s13045-022-01391-4

Chicago Style (17th ed.) Citation

Fu, Kai, Fachao Xie, Fang Wang, and Liwu Fu. "Therapeutic Strategies for EGFR-mutated Non-small Cell Lung Cancer Patients with Osimertinib Resistance." Journal of Hematology and Oncology 15, no. 1 (2022): 173-32. https://doi.org/10.1186/s13045-022-01391-4.

MLA (9th ed.) Citation

Fu, Kai, et al. "Therapeutic Strategies for EGFR-mutated Non-small Cell Lung Cancer Patients with Osimertinib Resistance." Journal of Hematology and Oncology, vol. 15, no. 1, 2022, pp. 173-32, https://doi.org/10.1186/s13045-022-01391-4.